Literature DB >> 19565364

Acute renal failure related to oxaliplatin-induced intravascular hemolysis.

Ayhan Ulusakarya1, Srimanta Misra, Mazen Haydar, Hélène Habert, Vincent Castagne, Yusuf Gumus, Béatrice Delmas-Marsalet, David Machover.   

Abstract

Oxaliplatin is an effective chemotherapeutic agent frequently used in the treatment of colorectal carcinoma. Rare cases of renal failure and hemolytic reactions have been reported as separate side effects of oxaliplatin. Here we present a clinical picture of immune-related intravascular hemolysis and acute tubular necrosis in a patient receiving this drug. This case suggests a mechanistic explanation of renal failure in patients treated with oxaliplatin.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19565364     DOI： 10.1007/s12032-009-9263-3

Source DB:  PubMed          Journal:  Med Oncol        ISSN： 1357-0560            Impact factor:   3.064


  5 in total

1.  A case of acute tubular necrosis due to oxaliplatin.

Authors:  G Pinotti; B Martinelli
Journal:  Ann Oncol       Date:  2002-12       Impact factor: 32.976

2.  An immediate hemolytic reaction induced by repeated administration of oxaliplatin.

Authors:  Vivien M Y Chen; Karen M Thrift; Marie-Christine Morel-Kopp; David Jackson; Christopher M Ward; Robert L Flower
Journal:  Transfusion       Date:  2004-06       Impact factor: 3.157

3.  Renal toxicity of oxaliplatin.

Authors:  Jacques Labaye; Damien Sarret; Christan Duvic; Michel Hérody; Francis Didelot; Georges Nédélec; Laure-Hélène Noël
Journal:  Nephrol Dial Transplant       Date:  2005-04-12       Impact factor: 5.992

4.  Oxaliplatin-induced immune hemolytic anemia: a case report and review of the literature.

Authors:  Francesc Cobo; Guillem De Celis; Arturo Pereira; Xavier Latorre; Jaume Pujadas; Santiago Albiol
Journal:  Anticancer Drugs       Date:  2007-09       Impact factor: 2.248

5.  Positive direct and indirect antiglobulin tests associated with oxaliplatin can be due to drug antibody and/or drug-induced nonimmunologic protein adsorption.

Authors:  Patricia Arndt; George Garratty; Edahn Isaak; Michael Bolger; Qun Lu
Journal:  Transfusion       Date:  2009-12-15       Impact factor: 3.157
  5 in total
  8 in total

Review 1.  Nanocarriers for delivery of platinum anticancer drugs.

Authors:  Hardeep S Oberoi; Natalia V Nukolova; Alexander V Kabanov; Tatiana K Bronich
Journal:  Adv Drug Deliv Rev       Date:  2013-10-08       Impact factor: 15.470

2.  A rare case of acute kidney injury associated with autoimmune hemolytic anemia and thrombocytopenia after long-term usage of oxaliplatin.

Authors:  Isao Ito; Yasuhiko Ito; Masashi Mizuno; Yasuhiro Suzuki; Kaoru Yasuda; Takenori Ozaki; Tomoki Kosugi; Yoshinari Yasuda; Waichi Sato; Naotake Tsuboi; Shoichi Maruyama; Enyu Imai; Seiichi Matsuo
Journal:  Clin Exp Nephrol       Date:  2012-03-27       Impact factor: 2.801

3.  A new approach to reduce toxicities and to improve bioavailabilities of platinum-containing anti-cancer nanodrugs.

Authors:  Li Liu; Qing Ye; Maggie Lu; Ya-Chin Lo; Yuan-Hung Hsu; Ming-Cheng Wei; Yu-Hsiang Chen; Shen-Chuan Lo; Shian-Jy Wang; Daniel J Bain; Chien Ho
Journal:  Sci Rep       Date:  2015-06-03       Impact factor: 4.379

4.  Severe acute tubular necrosis observed subsequent to oxaliplatin administration.

Authors:  Niall Filewod; Mark L Lipman
Journal:  Clin Kidney J       Date:  2013-12-29

5.  Preparation and In Vivo Evaluation of Dichloro(1,2-Diaminocyclohexane)platinum(II)-Loaded Core Cross-Linked Polymer Micelles.

Authors:  Hardeep S Oberoi; Natalia V Nukolova; Yi Zhao; Samuel M Cohen; Alexander V Kabanov; Tatiana K Bronich
Journal:  Chemother Res Pract       Date:  2012-07-15

6.  Cytoreduction with Hyperthermic Intraperitoneal Chemotherapy and Renal Insufficiency Related to Diabetes Mellitus: An Anesthetic Challenge.

Authors:  Adrian Bartos; Caius Breazu; Dana Bartos; Lidia Ciobanu; Calin Mitre
Journal:  J Crit Care Med (Targu Mures)       Date:  2017-11-08

7.  Urinary biomarkers for early detection of platinum based drugs induced nephrotoxicity.

Authors:  Mostafa Abdelsalam; Ekramy Elmorsy; Hassan Abdelwahab; Osman Algohary; Mahmoud Naguib; Ahmed Abd El Wahab; Ahmed Eldeeb; Ehab Eltoraby; Adel Abdelsalam; Alaa Sabry; Mohamed El-Metwally; Mohamed Akl; Nahla Anber; Maysaa El Sayed Zaki; Fahad Almutairi; Tamer Mansour
Journal:  BMC Nephrol       Date:  2018-09-04       Impact factor: 2.388

Review 8.  The Predictive Role of the Biomarker Kidney Molecule-1 (KIM-1) in Acute Kidney Injury (AKI) Cisplatin-Induced Nephrotoxicity.

Authors:  Daniela Maria Tanase; Evelina Maria Gosav; Smaranda Radu; Claudia Florida Costea; Manuela Ciocoiu; Alexandru Carauleanu; Cristina Mihaela Lacatusu; Minela Aida Maranduca; Mariana Floria; Ciprian Rezus
Journal:  Int J Mol Sci       Date:  2019-10-22       Impact factor: 5.923
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.